Activity-based probes that target diverse cysteine protease families

被引:282
作者
Kato, D
Boatright, KM
Berger, AB
Nazif, T
Blum, G
Ryan, C
Chehade, KAH
Salvesen, GS
Bogyo, M
机构
[1] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94030 USA
[2] Stanford Univ, Sch Med, Canc Biol Grad Program, Stanford, CA 94030 USA
[3] Burnham Inst, La Jolla, CA 92037 USA
[4] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA
[5] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94030 USA
关键词
D O I
10.1038/nchembio707
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Proteases are one of the largest and best-characterized families of enzymes in the human proteome. Unfortunately, the understanding of protease function in the context of complex proteolytic cascades remains in its infancy. One major reason for this gap in understanding is the lack of technologies that allow direct assessment of protease activity. We report here an optimized solid-phase synthesis protocol that allows rapid generation of activity-based probes (ABPs) targeting a range of cysteine protease families. These reagents selectively form covalent bonds with the active-site thiol of a cysteine protease, allowing direct biochemical profiling of protease activities in complex proteomes. We present a number of probes containing either a single amino acid or an extended peptide sequence that target caspases, legumains, gingipains and cathepsins. Biochemical studies using these reagents highlight their overall utility and provide insight into the biochemical functions of members of these protease families.
引用
收藏
页码:33 / 38
页数:6
相关论文
共 28 条
[1]   Aza-peptide epoxides: A new class of inhibitors selective for clan CD cysteine proteases [J].
Asgian, JL ;
James, KE ;
Li, ZZ ;
Carter, W ;
Barrett, AJ ;
Mikolajczyk, J ;
Salvesen, GS ;
Powers, JC .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (23) :4958-4960
[2]  
Berger Alicia B, 2004, Am J Pharmacogenomics, V4, P371, DOI 10.2165/00129785-200404060-00004
[3]   Mechanisms of caspase activation [J].
Boatright, KM ;
Salvesen, GS .
CURRENT OPINION IN CELL BIOLOGY, 2003, 15 (06) :725-731
[4]   Selective targeting of lysosomal cysteine proteases with radiolabeled electrophilic substrate analogs [J].
Bogyo, M ;
Verhelst, S ;
Bellingard-Dubouchaud, V ;
Toba, S ;
Greenbaum, D .
CHEMISTRY & BIOLOGY, 2000, 7 (01) :27-38
[5]   Identification of the active site of legumain links it to caspases, clostripain and gingipains in a new clan of cysteine endopeptidases [J].
Chen, JM ;
Rawlings, ND ;
Stevens, RAE ;
Barrett, AJ .
FEBS LETTERS, 1998, 441 (03) :361-365
[6]   Activation of human prolegumain by cleavage at a C-terminal asparagine residue [J].
Chen, JM ;
Fortunato, M ;
Barrett, AJ .
BIOCHEMICAL JOURNAL, 2000, 352 :327-334
[7]   Human caspase-7 activity and regulation by its N-terminal peptide [J].
Denault, JB ;
Salvesen, GS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (36) :34042-34050
[8]   MODIFICATION OF S-1 SUBSITE SPECIFICITY IN THE CYSTEINE PROTEASE CATHEPSIN-B [J].
FOX, T ;
MASON, P ;
STORER, AC ;
MORT, JS .
PROTEIN ENGINEERING, 1995, 8 (01) :53-57
[9]   Autocatalytic activation of human legumain at aspartic acid residues [J].
Halfon, S ;
Patel, S ;
Vega, F ;
Zurawski, S ;
Zurawski, G .
FEBS LETTERS, 1998, 438 (1-2) :114-118
[10]   Chemical proteomics and its application to drug discovery [J].
Jeffery, DA ;
Bogyo, M .
CURRENT OPINION IN BIOTECHNOLOGY, 2003, 14 (01) :87-95